and prescription drugs
Professional content for our medical and pharmaceutical visitors. The information in this section is for healthcare specialists only!Learn more
Our products are available in 65 countriesClick here to learn more
Egis activities extend to every field of the pharmaceutical value chainClick here to learn more
Egis is an innovation-oriented generic pharma company, one of the regional industry leaders.Click here to learn more
EGIS-RUS announces the expansion of its Women’s health portfolio by a new brand under Zalain product line. It will be replenished with the new Zalagel® Intim moisturizing gel for intimate hygiene with a unique combination of tea tree oil and weakly alkaline pH 8-9.
EGIS-RUS LLC made rebranding of the popular skin repair products: D-Panthenol Novatenol (cream and ointment) took place D-Panthenol (cream and ointment) on pharmacy shelves.
The Semmelweis University and Egis Pharmaceuticals PLC have agreed on an even closer and better structured cooperation than before. Their common goal is to further raise the standards of pharmaceutical R+D as well as pharmacist and doctor training by making use of the synergies in each other’s activities. As a result of the agreement, new health industrial innovations can be launched and the Semmelweis University can be extended with more practical educational and training elements that also meet the needs of the Hungarian pharmaceutical industry.
November 21, 2019: A symposium “New opportunities for reducing cardiovascular risk in the Russian Federation”, organized by EGIS-RUS, was held in the frame of the XIV National Congress of Therapists.
New Year is a time of miracles and cherished wishes, it is essentially about and for children. Therefore, EGIS-RUS decided to give them a charity Christmas Tree “Chain of Good”. On December 21, 2019, EGIS-RUS’ office opened its doors for the children of the employees and young guests from the orphanage in Moscow.
Hungarian-based Egis Pharmaceuticals PLC launch in Russia the first fixed drug combination of two lipid-lowering agents: rosuvastatin and ezetimibe.
From October 7 to December 22, 2019, there will be a TV broadcasting campaign in support of Sinuforte®. The commercial under the slogan “Do not let sinusitis cling on to you” is broadcasting on the largest federal television channels: Russia, TNT, Muz-TV, Friday, Channel 5, TV-3, Disney, U.
Egis Russia’s Buy for Good campaign that was carried out in 2018 won the award of ‘Best Social Projects in Russia’ in the category of medical and social projects.
Egis ’products are available in 65 countries. Our portfolio consists of 629 products. Our main focus lies on treating diseases of the cardiovascular and central nervous systems.Learn more about our products